CHEMON INC. Inactive Instrument
ChemOn Inc. Stock
Equities
A217600
KR7217600006
Biotechnology & Medical Research
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Si-Hwan Song
CEO | Chief Executive Officer | 63 | 17-03-28 |
Hyun-Gul Lee
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-06-30 |
Jun-Sub Yoon
AUD | Comptroller/Controller/Auditor | 75 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Si-Hwan Song
CEO | Chief Executive Officer | 63 | 17-03-28 |
Hyun-Gul Lee
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-06-30 |
Gil-Ahn Yang
BRD | Director/Board Member | 68 | 18-08-31 |
Chemon Inc is a Korea-based company principally engaged in the provision of research and development services. The Company is engaged in the research and development of pharmaceuticals, foods, chemicals, cosmetics and other new substances. In addition, the Company is engaged in the research and development of natural science and engineering.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.13% | 43.43B | |
| +48.83% | 41.69B | |
| +8.49% | 41.31B | |
| -10.82% | 27.14B | |
| +8.26% | 25.28B | |
| -23.69% | 18.47B | |
| +1.58% | 12.33B | |
| +32.83% | 12.59B | |
| +6.63% | 11.03B |
